William Bradley Coley | |
|---|---|
 | |
| Born | January 12, 1862 Westfield, Connecticut, U.S. |
| Died | April 16, 1936 (aged 74) New York City, U.S. |
| Education | Yale University, Harvard Medical School, Weill Cornell Medical Center |
| Occupation | Surgeon |
| Known for | Cancer immunotherapy |
| Parent(s) | Horace Bradley Coley Clarina B. Wakeman |
William Bradley Coley (January 12, 1862 – April 16, 1936) was an American bone surgeon and cancer researcher best known for his early contributions to the study of cancer immunotherapy, specifically causing infection as a way to fight cancer, a practice used as far back as 1550 BC.[1] His work was not proven effective in his lifetime, and today Coley's toxins are known to be both ineffective and potentially harmful. Coley is nevertheless recognized as the Father of Cancer Immunotherapy for his contributions to the science.[2]
- ^ Thomas Jessy (2011). "Immunity over inability: The spontaneous regression of cancer". Journal of Natural Science, Biology, and Medicine. 2 (1): 43–49. doi:10.4103/0976-9668.82318. PMC 3312698. PMID 22470233.
- ^ Cite error: The named reference
acswas invoked but never defined (see the help page).